Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition
Refractory Multiple Myeloma (RRMM)
Sex
Male or Female
Age
18+ years
Healthy participants
No

Eligibility criteria

Study overview

The purpose of this study is to evaluate:

  • What is the real-world effectiveness of elranatamab in patients with relapsed and/or refractory multiple myeloma (RRMM) in Taiwan?
  • What are the baseline and clinical characteristics of RRMM patients who have received eltanatamab in Taiwan?
  • What are the treatment patterns of RRMM patients receiving elranatamab in the real-world setting in Taiwan?

View locations for this study

Find the closest location, your results will be shown below
Find the closest location
    Miles
    0500

    Nearest Locations found

    1 site found

    Taichung Veterans General Hospital

    Taichung, Taiwan, 40705
    Site Info
    • Recruitment Status
    • Site details
    • Study Contact
    • Clinical Trials ID

    Study Locations

    View locations for this studyFind the closest location, your results will be shown belowFind the closest location